Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Carrier

Showing results (381-390 of 422) with videos related to

Pageof 43
Sort By:
Trials|March 11, 2021
Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trialMichelle Sholzberg, Grace H Tang, Elnara Negri, et al.
Chest|August 22, 2021
VTE Prophylaxis in Critically Ill Adults: A Systematic Review and Network Meta-analysisShannon M Fernando, Alexandre Tran, Wei Cheng, et al.
BMJ (Clinical Research Ed.)|September 13, 2022
Efficacy and safety of extended duration to perioperative thromboprophylaxis with low molecular weight heparin on disease-free survival after surgical resection of colorectal cancer (PERIOP-01): multicentre, open label, randomised controlled trialRebecca C Auer, Michael Ott, Paul Karanicolas, et al.
The Lancet. Haematology|November 13, 2016
Anticoagulant therapy for symptomatic calf deep vein thrombosis (CACTUS): a randomised, double-blind, placebo-controlled trialMarc Righini, Jean-Philippe Galanaud, Hervé Guenneguez, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|December 1, 2022
On-treatment Comparative Effectiveness of Vitamin K Antagonists and Direct Oral Anticoagulants in GARFIELD-VTE, and Focus on Cancer and Renal DiseaseSylvia Haas, Alfredo E Farjat, Karen Pieper, et al.
The New England Journal of Medicine|December 5, 2018
Apixaban to Prevent Venous Thromboembolism in Patients with CancerMarc Carrier, Karim Abou-Nassar, Ranjeeta Mallick, et al.
Haematologica|February 6, 2025
Multinational cohort study of intracranial hemorrhage in patients with brain metastases receiving anticoagulationEva N Hamulyák, Tzu-Fei Wang, Lisa Baumann Kreuziger, et al.
Blood Vessels, Thrombosis & Hemostasis|March 19, 2026
Intracranial hemorrhage in patients with primary brain cancer receiving anticoagulationEva N Hamulyák, Tzu-Fei Wang, Lisa Baumann Kreuziger, et al.
European Heart Journal|June 27, 2025
Predictors of recurrent venous thromboembolism and bleeding in patients with cancer: a meta-analysisFaizan Khan, Tobias Tritschler, Caterina E Marx, et al.
BMJ (Clinical Research Ed.)|July 26, 2019
Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysisFaizan Khan, Alvi Rahman, Marc Carrier, et al.
Pageof 43

Showing results (381-390 of 422) with videos related to

Sort By:
Pageof 43
Trials|March 11, 2021
Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trialMichelle Sholzberg, Grace H Tang, Elnara Negri, et al.
Chest|August 22, 2021
VTE Prophylaxis in Critically Ill Adults: A Systematic Review and Network Meta-analysisShannon M Fernando, Alexandre Tran, Wei Cheng, et al.
BMJ (Clinical Research Ed.)|September 13, 2022
Efficacy and safety of extended duration to perioperative thromboprophylaxis with low molecular weight heparin on disease-free survival after surgical resection of colorectal cancer (PERIOP-01): multicentre, open label, randomised controlled trialRebecca C Auer, Michael Ott, Paul Karanicolas, et al.
The Lancet. Haematology|November 13, 2016
Anticoagulant therapy for symptomatic calf deep vein thrombosis (CACTUS): a randomised, double-blind, placebo-controlled trialMarc Righini, Jean-Philippe Galanaud, Hervé Guenneguez, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|December 1, 2022
On-treatment Comparative Effectiveness of Vitamin K Antagonists and Direct Oral Anticoagulants in GARFIELD-VTE, and Focus on Cancer and Renal DiseaseSylvia Haas, Alfredo E Farjat, Karen Pieper, et al.
The New England Journal of Medicine|December 5, 2018
Apixaban to Prevent Venous Thromboembolism in Patients with CancerMarc Carrier, Karim Abou-Nassar, Ranjeeta Mallick, et al.
Haematologica|February 6, 2025
Multinational cohort study of intracranial hemorrhage in patients with brain metastases receiving anticoagulationEva N Hamulyák, Tzu-Fei Wang, Lisa Baumann Kreuziger, et al.
Blood Vessels, Thrombosis & Hemostasis|March 19, 2026
Intracranial hemorrhage in patients with primary brain cancer receiving anticoagulationEva N Hamulyák, Tzu-Fei Wang, Lisa Baumann Kreuziger, et al.
European Heart Journal|June 27, 2025
Predictors of recurrent venous thromboembolism and bleeding in patients with cancer: a meta-analysisFaizan Khan, Tobias Tritschler, Caterina E Marx, et al.
BMJ (Clinical Research Ed.)|July 26, 2019
Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysisFaizan Khan, Alvi Rahman, Marc Carrier, et al.
Pageof 43